Publications

Journal Article Epublish
Electronic publication date
May 28, 2025

View on Pubmed.gov 40433630 | View on doi.org 10.1080/2000229...

Amoxicillin-metronidazole disk for antimicrobial susceptibility testing of subgingival bacteria.

Search for publications in this journal J Oral Microbiol - 17(1):2508479

Abstract

Background

Antibiotics are used in periodontal therapy in selected cases, but therapy is rarely guided by antimicrobial susceptibility testing (AST). Direct AST of the oral microbiota using a combination disk with different antibiotics could provide a new way of AST to guide treatment planning.

Methods

We performed AST of 46 strains of Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum complex, Prevotella species, and Porphyromonas gingivalis, with a combination disk of amoxicillin (AMX) and metronidazole (MET). The AMX-MET was compared to the largest inhibition zone diameter (IZD) obtained with AMX or MET disks, using an ordinary least square linear regression model.

Results

The IZD of the AMX-MET correlated with the AMX for A. actinomycetemcomitans (interception 0.3) and with the MET for Fusobacterium (interceptions -1.25). For Prevotella, the AMX-MET was compared to AMX and MET after 20 and 44 h resulting in a superior correlation after 20 h (interception 0.06 vs 6.61 after 44 h). For P. gingivalis, the AMX-MET was compared to MET after 44 h resulting in an inferior correlation (interception 16.65).

Conclusion

The IZD of AMX-MET was comparable to that of AMX and MET for important periodontal pathogens, which opens for studies on direct AST of oral samples with a mixed microbiota.

Key message

The amoxicillin-metronidazole disk for antimicrobial susceptibility testing results in comparable inhibition zone diameters to that of AMX and MET for important periodontal pathogens.

References

J Periodontol. 2017 Dec;88(12):1263-1270

J Antimicrob Chemother. 1994 Dec;34(6):1047-50

J Clin Microbiol. 1986 Mar;23(3):441-5

Clin Microbiol Infect. 2021 Nov;27(11):1695.e1-1695.e6

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

MeSH

Specialties

Copyright

© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.